VON Hardenberg J - Search Results

1

Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy.

Neuberger M, Skladny J, Goly N, Wessels F, WEIß C, Egen L, Erben P, GROß-Weege M, Grüne B, Hartung F, Herrmann J, Honeck P, Jarczyk J, Kowalewski KF, Mühlbauer J, Nitschke K, Nientiedt M, Walach MT, Waldbillig F, Westhoff N, VON Hardenberg J, Kriegmair M, Worst TS, Nuhn P. Neuberger M, et al. Among authors: von hardenberg j. Anticancer Res. 2022 Apr;42(4):1911-1918. doi: 10.21873/anticanres.15668. Anticancer Res. 2022. PMID: 35347010

2

[Abstracts at congresses of the German Society of Urology. Trends and quality].

von Hardenberg J, Worst T, Weiß C, Michel MS. von Hardenberg J, et al. Urologe A. 2013 Sep;52(9):1296-301. doi: 10.1007/s00120-013-3304-4. Urologe A. 2013. PMID: 23942740 German.

3

Influence of abiraterone acetate on circulating neuromediators in chemotherapy-naïve castration-resistant prostate cancer.

von Hardenberg J, Schwartz M, Werner T, Fuxius S, Müller M, Bolenz C, Weiß C, Heinrich E. von Hardenberg J, et al. Prostate. 2016 May;76(7):613-9. doi: 10.1002/pros.23152. Epub 2016 Jan 15. Prostate. 2016. PMID: 26779767

4

Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine.

Wezel F, Erben P, Gaiser T, Budjan J, von Hardenberg J, Michel MS, Bolenz C. Wezel F, et al. Among authors: von hardenberg j. Urol Int. 2018;100(1):122-125. doi: 10.1159/000443280. Epub 2016 Jan 19. Urol Int. 2018. PMID: 26780095

5

Precision of MRI/ultrasound-fusion biopsy in prostate cancer diagnosis: an ex vivo comparison of alternative biopsy techniques on prostate phantoms.

Westhoff N, Siegel FP, Hausmann D, Polednik M, von Hardenberg J, Michel MS, Ritter M. Westhoff N, et al. Among authors: von hardenberg j. World J Urol. 2017 Jul;35(7):1015-1022. doi: 10.1007/s00345-016-1967-3. Epub 2016 Nov 9. World J Urol. 2017. PMID: 27830373

6

RAB27A, RAB27B and VPS36 are downregulated in advanced prostate cancer and show functional relevance in prostate cancer cells.

Worst TS, Meyer Y, Gottschalt M, Weis CA, von Hardenberg J, Frank C, Steidler A, Michel MS, Erben P. Worst TS, et al. Among authors: von hardenberg j. Int J Oncol. 2017 Mar;50(3):920-932. doi: 10.3892/ijo.2017.3872. Epub 2017 Feb 10. Int J Oncol. 2017. PMID: 28197629

7

Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.

Worst TS, von Hardenberg J, Gross JC, Erben P, Schnölzer M, Hausser I, Bugert P, Michel MS, Boutros M. Worst TS, et al. Among authors: von hardenberg j. Mol Cell Proteomics. 2017 Jun;16(6):998-1008. doi: 10.1074/mcp.M117.068577. Epub 2017 Apr 9. Mol Cell Proteomics. 2017. PMID: 28396511 Free PMC article.

8

Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review.

von Hardenberg J, Schwartz M, Werner T, Fuxius S, Strauss A, Worst TS, Nuhn P, Bolenz C, Heinrich E. von Hardenberg J, et al. Urol Int. 2017;99(4):414-421. doi: 10.1159/000477943. Epub 2017 Jul 13. Urol Int. 2017. PMID: 28700990 Review.

9

Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer?

Hausmann D, Aksöz N, von Hardenberg J, Martini T, Westhoff N, Buettner S, Schoenberg SO, Riffel P. Hausmann D, et al. Among authors: von hardenberg j. Eur Radiol. 2018 Feb;28(2):869-876. doi: 10.1007/s00330-017-5004-8. Epub 2017 Aug 10. Eur Radiol. 2018. PMID: 28799090

10

Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel.

VON Hardenberg J, Schwartz M, Werner T, Fuxius S, Müller M, Frangenheim T, Bolenz C, Weiss C, Heinrich E. VON Hardenberg J, et al. Anticancer Res. 2017 Sep;37(9):5117-5124. doi: 10.21873/anticanres.11931. Anticancer Res. 2017. PMID: 28870943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page